On behalf of the Stroke 2018 committee, we are pleased to invite you to join the upcoming “6th International Conference on Neurodegenerative Disorders and Stroke” to be held during July 05-06, 2018 in Vienna, Austria.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and Pulsus Group..
Scientific Discussion on Neurodegenerative disorders
Neurological disorders are those that involve impairments in the nervous system. All the body's movements and functions are coordinated by the nervous system and there are more than 600 diseases of the brain, spine and the nerves that connect them such as brain tumor, Parkinson's disease, epilepsy, stroke and less familiar ones such as front temporal dementia.
Scientific Discussion on Etiology of stroke and risk factors
Risk of stroke and second stroke is influenced by several factors like conditions, behavior, and family history and other characteristics. They fall into three groups: Stroke risk factors that you cannot control such as Age, Gender, and A family history of stroke. Medical stroke risk factors like Transient Ischemic Attack (TIA), Atrial Fibrillation, Diabetes, and Fibro Muscular Dysplasia (FMD). Lifestyle stroke risk factors that you can control such as, cigarette smoking, high cholesterol, Obesity or being overweight, poor diet and lack of exercise and drinking too much alcohol.
Scientific Discussion on Preventive Stroke Strategies
Prevention of stroke may be classified as primary prevention if there is no previous history of stroke or transient ischemic attack (TIA) and secondary prevention if there has been such an event. Primary prevention of stroke includes lifestyle modifications and measures to control cholesterol levels, diabetes mellitus, blood pressure and atrial fibrillation. Reducing blood pressure in patients with hypertension prevents both hemorrhagic and ischemic stroke. The research studies suggest that higher cholesterol levels are associated with an increased risk of ischemic stroke and treatment with statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) may reduce the risk of fatal and nonfatal stroke.
Scientific Discussion on Neuro Oncology
Neuro-Oncology is study of treatment for patients with cancers of the brain and nervous system.
There are some of the conditions and symptoms which includes: Acoustic neuroma, Brain metastases, Astrocytoma, Chordoma, Ependymoma, Craniopharyngioma, Glioblastoma multiforme, Glioma, Lymphoma, Meningioma, Medulloblastoma, Oligodendroglioma, Brain tumors, Pineal tumor and Schwannoma.
Scientific Discussion on Stroke and Mental Health
A stroke is an emergency of medical aspect that requires early treatment that indicates early action can minimize brain damage and potential complications. Person affected by stroke addresses cognition and/or behavioral problems that includes problems using languages, vision and perception problems and sudden bursts of emotions.
Scientific Discussion on Dementia
Dementia is a syndrome characterized by cognitive or memory impairments that describes the symptoms of many conditions that affects the brain. The commonly seen conditions are Alzheimer’s and Parkinson’s disease. Symptoms seen at early stages are memory loss, personality changes, withdrawal and confusion.
Scientific Discussion on Vascular and brain imaging
Stroke is the third leading cause of death in Europe, USA, Canada and Japan and is the primary cause of adult disability and in this 80% are ischemic such as cardiogenic, atherosclerotic, hemodynamic, lacunar and cryptogenic. Cranial CT is the most useful initial imaging modality to differentiate between ischemia and hemorrhage, and to exclude stroke mimics. Vascular imaging is a key component in the brain stroke 2018 International Conference for comprehensive stroke diagnosis and cause based therapy. Siemens supports with the full spectrum of angiography systems available today. Siemens analysis tools reduce the information load by removing distracting visual input (e.g. skull base) in intra-arterial (X-ray), CT, MR, and US angiography. Consequently, it assists in focusing on vascular changes and interventional procedures such as clot removal, thrombolysis and stent implantation. Tools for imaging of brain function includes Magnetic resonance spectroscopy, Single photon emission computed tomography, Functional magnetic resonance imaging (fMRI), Magnetoencephalography (MEG).
Scientific Discussion on Hemorrhagic Stroke
Hemorrhagic stroke involves bleeding within the brain, which damages nearby brain tissue and there are two types of hemorrhagic stroke: intracranial hemorrhage (ICH), which occurs with bleeding into the brain tissue and subarachnoid hemorrhage (SAH), which occurs with bleeding into the subarachnoid space beneath the arachnoid mater of the meninges. Causes of hemorrhagic stroke include Aneurysms, arteriovenous malformation (AVM), and Cerebral amyloid angiopathy.
Scientific Discussion on Stroke Rehabilitation and Recovery
Stroke is one of the main leading causes of long term adult disability which is affecting approximately 795,000 people each year in the USA.
Someone who suffered a stroke can improve functions and sometimes remarkable recoveries by early recovery and rehabilitation.
The goal of a stroke rehabilitation program is to help you relearn skills which are lost when stroke affected part of your brain. Stroke rehabilitation can help to regain independence and improve the quality of life.
Scientific Discussion on Pediatrics: Stroke and metabolic disorders
Stroke is more common in boys than girls even after controlling for differences in frequency of causes trauma and these appears to be a predominance of stroke in black children. This difference remains true even after accounting for sickle cell disease patients with stroke and moreover seizures are common in both ischemic and hemorrhagic strokes. They occur in up to 50% of children with strokes are not restricted to any age group and are not limited to any specific seizure type. A stroke or cerebral vascular accident (CVA) in children is typically considered to be a rare event. The reported incidence of combined and hemorrhagic ischemic pediatric stroke ranges from 1.2 to 13 cases per 100,000 children under 18 years of age.
Non-contrast head computed tomography (CT) is sensitive for acute bleeding and should be obtained emergently to exclude a cause for hemorrhagic stroke. Despite increasingly advanced imaging techniques the adult literature suggests that a lumbar puncture is still needed to rule out a subarachnoid hemorrhage.
Scientific Discussion on Stroke and Cancer- A Complicated Relationship
Cancer and ischemic stroke are two of the most common causes of death. However, the main path mechanisms of stroke in cancer patients are not well known and can only be established based on accurate knowledge of the characteristics of cancer and their related strokes. Ischemic stroke and cancer independently carry a large burden of morbidity and mortality as the second and fourth leading cause of death and they each represent an enormous expenditure as a percentage of health care resources, manifested by lost productivity and disrupted family structures due to death and dependency. Cancer patients frequently have strokes, both from traditional risk factors and from mechanisms thought unique to malignancy. The most frequent causes of stroke in cancer patients are traditional cerebrovascular risk factors such as hyperlipidemia, hypertension, diabetes, tobacco use and atrial fibrillation
Scientific Discussion on Vascular surgery and neurosurgery
The Neurovascular surgery specializes in the management of complex central nervous system vascular disorders including arteriovenous malformations, aneurysms, cavernous angiomas and carotid and intracerebral stenosis. Surgery and vascular procedures can be used to prevent stroke to treat or to repair damaged blood vessels or malformations in and around the brain. Carotid endarterectomy is a surgical procedure in which a surgeon removes fatty deposits or plaque from the inside of one of the carotid arteries and this procedure is performed to prevent stroke
Scientific Discussion on Current Breakthrough in Stroke Research
The randomized clinical research study shows a dramatic improvement in restoring blood back to the brain in arteries. This study involved minimally invasive clot procedure known as stent thrombectomy and this standard clot procedure called as tissue plasminogen activator. In patients with more severe strokes, each trail shows the striking benefit of catheter-based clot removal to restore blood flow in brain arteries. This can be used to improve the treatment for heart attacks known as acute stroke therapy. There is another new treatment for the stroke shown to be very effective that and it will be used as a part of standard stroke care
Scientific Discussion on Clinical Trials & Case Reports
Clinical trials and case reports includes the involvement of larger groups of people confirming the effectiveness of a drug or treatment, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely. This track gives researchers knowledge about new technologies, clinical trials and new aspects.
On behalf of Pulsus group, we are inviting all the participants from all over the world to attend our conference entitled “ 6th International Conference on Neurodegenerative Disorders and Stroke” to be held on July 05-06, 2018 in Vienna, Austria.
Stroke 2018 has been planning and aiming to stimulate new techniques for treatment of neurodegenerative disorders and stroke that would be beneficial for the neurosurgery.
The conference will be organized around the theme ‘Novel approaches & Development in Neurodegenerative disorders and Stroke’.
Pulsus Group is a medical journals publisher that publishes, promotes and disseminates the work of medical researchers in a manner that exemplifies the highest standards in research integrity. Pulsus group is in alliance with Germany and other medical research associations of international level. It publishes medical journals that emphasize on medical specialties like Integrative Medicine, Cardiology, Surgery and Reproductive Medicine. Pulsus group is an association with prominent academic and research societies like Germany Society of Plastic Surgeons, German Society for Aesthetic Plastic Surgery and Germany Society for Surgery of the Hand.
Pulsus Group is an international level publisher in scientific, technical, and medical journals established within the year 1984 with offices in Ontario and Canada, India has reaped Andrew John publishing and openaccessjournals.com to expand its Open Access publishing through its 50+ journals in association with 20+ International medical and scientific societies.
Globally the market for stroke disorder & treatments increasing rapidly. The major factor that derives the growth of stroke disorder & treatment is the increasing high blood pressure patients. Furthermore increasing alcoholism and patients with diabetes, cardiovascular diseases are increasing the growth of Stroke Disorder & Treatment market.Ischemic stroke is caused by a dysfunction in the supply of blood to the brain due to emboli, thrombus or atherosclerosis occurring in cerebral arteries. According to a World Health Organization (WHO) estimate, around 17 million people die every year due to cardiovascular diseases. Heart attacks and strokes respectively account for the highest number of deaths due to cardiovascular diseases, globally. The statistics of the Centres for Disease Control and Prevention suggest that about 87% of all strokes are ischemic strokes. Stroke is one of the leading cause of long term disability, occurring at a higher rate in the old age population. Moreover, stroke leads to 1 out of every 20 deaths, costing around $34 billion to U.S. annually. Higher rates of mortality associated with strokes highlight an impending need for innovative drugs and diagnostic devices.
The two major factors propelling the growth of the acute ischemic stroke diagnosis and treatment market are; large patient pools and a concerning rise in population at a higher risk of developing stroke in the near future. Rising incidence of diabetes along with heavy tobacco users and an increase in the ageing population are significant factors that determine the market growth. However, the high cost of treatment, lack of transparent reimbursement policies, and limited availability of expertise; are likely to restrict the market growth.
The global ischemic stroke diagnosis and treatment market is segmented on the basis of type and geography. According to type, the market is segmented into, diagnostics and therapeutics. The diagnostic market is further segmented into Computed Tomography Scan (CT scan), Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography and Blood tests. The therapeutic market further segments into Tissue Plasminogen Activator Anticoagulant, Antiplatelet and Antihypertensive. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific, and LAMEA.
New Product launches and collaborations are some of the key strategies adopted by leading industry players. In March, 2015, FDA approved WATCHMAN, a left atrial appendage closure device designed to prevent stroke in patients with atrial fibrillation. Silk Road Medical, Inc. has launched an Anti-Stroke Enroute Device, a transcarotid neuroprotection system, designed to access the common carotid artery through a minimally invasive technique. NeuroVive Pharmaceutical AB, entered into collaboration with BBB Therapeutics, for development of the NVP014 drug candidate used in the treatment of ischemic strokes.
The companies profiled in this report include, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Cordis Corporation, Koninklijke Philips N.V., GE Healthcare, Siemens AG, Stryker Corporation, Genentech, Inc. and Merck & Co., Inc.
KEY MARKET BENEFITS:
KEY MARKET SEGMENTS:
The global acute ischemic stroke diagnosis and treatment market is segmented below:
Acute Ischemic Stroke Diagnosis and Treatment Market By Type
Acute Ischemic Stroke Diagnosis and Treatment Market By Geography